NCT04257175 2023-11-28
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
Sheba Medical Center
Phase 2/3 Unknown
Clinical Trials
12 trialsNCT05203562 2022-07-12
Letrozole as a Prophylaxis From GTN for Complete Mole Patients
Zagazig University
Phase 2/3 Unknown
NCT02794337 2022-04-27
TACE-SBRT
Tata Memorial Hospital
Phase 2/3 Unknown
NCT03957733 2022-04-06
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Phase 2/3 Unknown
NCT04741880 2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3 Unknown
NCT03975036 2019-06-05
Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody
Henan Cancer Hospital
Phase 2/3 Unknown
NCT02741856 2018-10-25
SCOPE2
Velindre NHS Trust
Phase 2/3 Unknown
NCT03491410 2018-04-09
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included
Centro Hospitalar Lisboa Ocidental
Phase 2/3 Unknown
NCT03275727 2017-09-08
INNOVBC
Linkoeping University
Phase 2/3 Unknown
NCT02418247 2017-01-20
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
National Cancer Center, Korea
Phase 2/3 Unknown
NCT00450203 2016-12-01
ST03
Medical Research Council
Phase 2/3 Unknown
NCT00691236 2011-06-23
ZOL
Tata Memorial Hospital
Phase 2/3 Unknown